Update in autoimmune and paraneoplastic myelopathies: Newly described antigen targets and antibody testing.

MOG antibody associated diseases NMO spectrum disorder (NMOSD) autoimmune manifestations myelitis myelopathy paraneoplastic syndrome (PNS)

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2022
Historique:
received: 17 06 2022
accepted: 11 07 2022
entrez: 15 8 2022
pubmed: 16 8 2022
medline: 16 8 2022
Statut: epublish

Résumé

Myelopathy is an increasingly recognized presentation of many antibody-mediated neuroinflammatory disorders. While specific features of certain autoimmune myelopathies such as aquaporin-4 antibody associated neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein associated disorder (MOGAD) are well-characterized, other less commonly seen antibody-associated myelopathies are not as well-defined. These include but are not limited to, Hu/ANNA1, anti-glial fibrillary acidic protein (GFAP), anti-CV2/collapsin response mediator protein (CRMP5), and amphiphysin. Here, we review the mentioned more common antibody mediated myelopathies as well those that as less common, followed by a review of differentials that may mimic these disorders.

Identifiants

pubmed: 35968301
doi: 10.3389/fneur.2022.972143
pmc: PMC9366192
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

972143

Informations de copyright

Copyright © 2022 Passeri, Matthews, Kammeyer and Piquet.

Déclaration de conflit d'intérêts

Author AP reports grants from University of Colorado and Rocky Mountain MS Center, consulting fees from Genentech/Roche and Alexion, and also receive honorarium from Medlink and publication royalties from Springer as co-editor of a textbook. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Neurol Neurosurg Psychiatry. 1996 Sep;61(3):270-8
pubmed: 8795598
Arch Neurol. 1999 Feb;56(2):172-7
pubmed: 10025422
Neurology. 2020 Jul 14;95(2):e111-e120
pubmed: 32554760
Neurology. 2012 Feb 28;78(9):665-71; discussion 669
pubmed: 22302543
Neurology. 2015 Jul 14;85(2):177-89
pubmed: 26092914
Front Neurol. 2021 Sep 22;12:729075
pubmed: 34630302
J Neurochem. 1999 Jan;72(1):1-9
pubmed: 9886048
Continuum (Minneap Minn). 2019 Jun;25(3):815-844
pubmed: 31162318
J Neurol Sci. 2022 Jan 15;432:120086
pubmed: 34920159
Int J Mol Sci. 2020 Dec 24;22(1):
pubmed: 33374173
Mult Scler. 2021 Feb;27(2):303-308
pubmed: 32103708
Ann Neurol. 2003 May;53(5):580-7
pubmed: 12730991
Ann Neurol. 2017 Feb;81(2):298-309
pubmed: 28120349
BMJ Case Rep. 2017 Jun 28;2017:
pubmed: 28659367
Neurology. 2016 Aug 16;87(7):743-4
pubmed: 27527540
Front Immunol. 2018 Dec 05;9:2802
pubmed: 30568655
Ann Neurol. 2000 Mar;47(3):297-305
pubmed: 10716248
Neurology. 2017 Apr 4;88(14):1340-1348
pubmed: 28258082
Neurol Neuroimmunol Neuroinflamm. 2016 Sep 28;3(6):e285
pubmed: 27734022
Continuum (Minneap Minn). 2021 Feb 1;27(1):143-162
pubmed: 33522740
Neurology. 2014 Nov 11;83(20):1797-803
pubmed: 25320100
Neurol Neuroimmunol Neuroinflamm. 2020 Apr 8;7(4):
pubmed: 32269072
J Neurol. 2002 Jun;249(6):745-53
pubmed: 12111309
Ann Neurol. 2013 Jan;73(1):120-8
pubmed: 23225603
Continuum (Minneap Minn). 2021 Feb 1;27(1):62-92
pubmed: 33522737
J Neurol Neurosurg Psychiatry. 2021 Feb 9;:
pubmed: 33563803
J Neuroinflammation. 2015 Sep 17;12:168
pubmed: 26377319
Ann Neurol. 2008 Apr;63(4):531-4
pubmed: 18306241
Neurology. 2022 Feb 8;98(6):e653-e668
pubmed: 34799461
Mult Scler. 2020 Dec;26(14):1854-1865
pubmed: 31937191
JAMA Neurol. 2015 Jan;72(1):81-7
pubmed: 25384099
Acta Neuropathol. 1996;91(5):519-25
pubmed: 8740233
Oncoimmunology. 2013 Dec 1;2(12):e27384
pubmed: 24501693
Front Neurol. 2021 Oct 28;12:735895
pubmed: 34777203
Neurology. 2019 Nov 12;93(20):e1873-e1880
pubmed: 31624089
Neurology. 2014 Apr 29;82(17):1521-8
pubmed: 24696508
Muscle Nerve. 2017 Jul;56(1):15-27
pubmed: 28063151
Neurology. 1999 Nov 10;53(8):1719-23
pubmed: 10563618
J Neurol. 2020 Dec;267(12):3565-3577
pubmed: 32623595
Lancet. 2019 Oct 12;394(10206):1352-1363
pubmed: 31495497
Continuum (Minneap Minn). 2021 Feb 1;27(1):93-120
pubmed: 33522738
J Neurol. 2010 Jun;257(6):869-81
pubmed: 20232210
N Engl J Med. 2019 Nov 28;381(22):2114-2124
pubmed: 31774956
J Neurol Sci. 2020 Nov 15;418:117103
pubmed: 32877801
Continuum (Minneap Minn). 2021 Feb 1;27(1):121-142
pubmed: 33522739
Neurology. 2016 Mar 15;86(11):1009-13
pubmed: 26888994
JAMA Neurol. 2021 Jun 1;78(6):741-746
pubmed: 33900394
Ann Indian Acad Neurol. 2021 Sep-Oct;24(5):826-828
pubmed: 35002170
BMC Neurol. 2022 Apr 5;22(1):129
pubmed: 35382765
Handb Clin Neurol. 2016;133:327-51
pubmed: 27112686
J Neuroimmunol. 2020 Jul 15;344:577259
pubmed: 32416558
Neurology. 2021 Jan 26;96(4):e632-e639
pubmed: 33208548
Front Neurol. 2021 Oct 22;12:728700
pubmed: 34744969
Medicine (Baltimore). 2018 May;97(18):e0649
pubmed: 29718880
J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):214-7
pubmed: 10071102
Curr Opin Neurol. 2019 Jun;32(3):452-458
pubmed: 30724768
Neurol Clin. 2013 Feb;31(1):307-18
pubmed: 23186906
Neurology. 2018 Jan 9;90(2):e103-e110
pubmed: 29222126
Front Neurol. 2020 Sep 09;11:960
pubmed: 33013639
Continuum (Minneap Minn). 2021 Feb 1;27(1):163-184
pubmed: 33522741
JAMA Neurol. 2019 Mar 1;76(3):301-309
pubmed: 30575890

Auteurs

Michlene Passeri (M)

Department of Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

Elizabeth Matthews (E)

Department of Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

Ryan Kammeyer (R)

Department of Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Department of Pediatrics and Neurology, Children's Hospital Anschutz Medical Campus, Aurora, CO, United States.

Amanda L Piquet (AL)

Department of Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.

Classifications MeSH